111,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
56 °P sammeln
  • Broschiertes Buch

It is now generally recognized that clinical trial investigators and research scientists at the molecular, genetic, and cellular levels need to perform more detailed gender-based research in order to understand how sex-based differences impact women's health, illness, and health care. In Coronary Disease in Women: Evidence-Based Diagnosis and Treatment, leading authorities and clinical experts review the data concerning coronary disease in women and provide a clinical management approach to the care of women with known or suspected coronary artery disease. Whereas earlier books have focused on…mehr

Produktbeschreibung
It is now generally recognized that clinical trial investigators and research scientists at the molecular, genetic, and cellular levels need to perform more detailed gender-based research in order to understand how sex-based differences impact women's health, illness, and health care. In Coronary Disease in Women: Evidence-Based Diagnosis and Treatment, leading authorities and clinical experts review the data concerning coronary disease in women and provide a clinical management approach to the care of women with known or suspected coronary artery disease. Whereas earlier books have focused on gender-based differences in the epidemiology of coronary disease, or on gender bias in its treatment, the present work focuses on the daily, evidence-based clinical management of coronary disease in women. Working from the recommendations of the landmark Institute of Medicine's report, Exploring the Biological Contributions to Human Health: Does Sex Matter?, the authors apply the latest epidemiological findings and diagnostic tools to the evaluation of stable chest pain and acute ischemic syndromes in women. They also detail the therapeutic effectiveness of various treatments in women, such as coronary revascularization, electrophysiology, exercise training and cardiac rehabilitation, and menopausal hormone therapy. Additional chapters examine the effects of gender bias in diagnosis and treatment, the role of gynecologists as primary care physicians for women, health technology assessment in an era of managed care, and the problems of analyzing cost-effectiveness in the diagnosis and treatment of coronary artery disease in women.
Authoritative and timely, Coronary Disease in Women: Evidence-Based Diagnosis and Treatment provides primary care physicians, cardiologists, family practitioners, gynecologists, and internists with an up-to-date guide to the optimal management of coronary disease in women today.
Rezensionen
"...contemporary and up-to-date review of women and coronary artery disease." - Texas Heart Institute Journal "The book provides a good overview of the various ways in which women with known or suspected CAD differ from men, whether from the epidemiologic, clinical, or management perspective. This text will provide a wake-up call for clinicians who are not sufficiently sensitive to the potentially pernicious and corrosive effects of gender bias in the management of CAD in women." - Annals of Internal Medicine "There is much to be learned from this book..." -New England Journal of Medicine "Comprehensive and highly practical...offers both basic and clinical scientists an up-to-date collection of cutting edge protocols for solving he widest variety of novel flow cytometry problems." - Clin Lab "All methods are described in detail, and this book has the potential to become the geneticist's and biochemist's 'cook book' to study recombination in eukaryotes. It provides both experts and novices that want to move into the field of recombination with an accessible handbook...it provides trouble-shooting guides and the principles behind techniques as well as describing the basics of recombination." - ChemBioChem "...excellent book on all aspects of coronary artery disease (CAD) in women." - Doody's Health Sciences Book Review Journal